To the Editor: We would like to thank Christensen et al [1] for their thoughtful letter in response to our review on the pathophysiology of type 2 diabetes in sub-Saharan Africans [2]. Christensen et al [1] correctly highlight that aspects of infectious diseases and fetal programming by epigenetics were not discussed in depth in the review. This was certainly not due to their relative importance but merely due to word limitations and the scarcity of relevant mechanistic studies undertaken in sub-Saharan Africa (SSA).
Tuberculosis (TB) is the leading cause of deaths owing to infectious disease globally, and a quarter of TB cases in 2020 were from SSA [3]. Christensen et al [1] propose how delayed TB diagnosis in SSA may contribute to persistent inflammation that may eventually lead to beta cell dysfunction and increase the risk for type 2 diabetes. While this is an attractive hypothesis, there is little supporting evidence. In a meta-analysis of TB-associated hyperglycaemia including many studies from SSA, Menon et al [4] reported that hyperglycaemia may occur in ~10% of TB patients at diagnosis. It has been proposed that this is likely due to the stress response related to TB infection [5], which resolved in ~50% of patients after 3–6 months of TB treatment [4]. However, longer duration of follow-up is required to assess whether the transient hyperglycaemia observed with TB progresses to overt type 2 diabetes [4, 5].
While the evidence linking TB to type 2 diabetes risk is inconclusive, there is consistent evidence, mainly from high-income countries, to show that type 2 diabetes is associated with an increased risk of developing latent and active TB [6]. Even though the evidence from SSA is scarce, a recent systematic review including studies from SSA (n=9) reported a 2.8-fold (95% CI 1.9, 4.1) higher risk for TB among those with type 2 diabetes than without [7]. This estimate appears slightly higher than that reported in global reviews [6], possibly attributed to poorer glycaemic control in individuals from SSA. Nonetheless, individuals with TB and type 2 diabetes have a greater predisposition to treatment failure, infection relapses and increased mortality [8]. Hence, an improved understanding of the bidirectional relationship between TB and type 2 diabetes is essential to prevent the dual burden and associated morbidity and mortality.
Type 2 diabetes has also been shown to increase susceptibility to other infectious diseases such as malaria. SSA carried the burden of malaria cases and deaths in 2020 (95% and 96% of global cases and deaths, respectively) [9]. Studies have shown an increased risk for Plasmodium falciparum (malaria) infection in individuals with type 2 diabetes, with the risk and virulence of the infection increasing with increasing blood glucose concentrations [10, 11]. Hence, with the increasing rise in projected rates of type 2 diabetes in SSA [12], the already high burden of infectious diseases will be exacerbated.
In addition to the high prevalence of infectious disease, SSA is grappling with a high burden of obesity that is impacting women of reproductive age [13]. Consequently, pregnancies in SSA are often complicated by obesity and obesity-related conditions, such as gestational diabetes (GDM), as highlighted by Christensen et al [1]. A meta-analysis on the prevalence of GDM in Africa estimated a pooled prevalence of 14.3% in SSA [14]. The impact of GDM on type 2 diabetes burden was illustrated by a study conducted in South Africa where about one-third of women with GDM developed type 2 diabetes within 5–6 years postpartum [15]. Further, children born to women with GDM are more likely to develop type 2 diabetes later in life, thus enabling the perpetuation of the type 2 diabetes burden in the next generation, most likely through epigenetic mechanisms [16]. Indeed, a recent study conducted in South Africa reported epigenetic alterations in the blood of pregnant women and in the placental tissues of fetuses, resulting in reductions in the expression of glucose 6-phosphate dehydrogenase and genes encoding insulin-like growth factor-binding proteins, respectively [17]. This study proposed a pathophysiological link between these epigenetic modifications, adverse pregnancy outcomes and fetal macrosomia. Other studies have similarly reported altered epigenetic marks in South African women with GDM [18,19,20,21]. Although these studies did not measure the epigenetic profiles of the children, they showed that HIV modifies the epigenetic profiles of women with GDM [18, 21]. Accordingly, further studies are required to examine the epigenetic underpinnings of GDM on type 2 diabetes risk in the mother and offspring in SSA. It is essential that these studies explore interactions with infectious diseases such as HIV, as ~30% of all pregnant women in South Africa are living with HIV [22].
Notably, there are ongoing cohort studies in SSA that are observing the life trajectories of mothers and their children that may be harnessed to explore the epigenetic mechanisms that may lead to type 2 diabetes. Examples of these studies include the Epigenetic Mechanisms linking Pre-conceptional nutrition and Health Assessed in India and SSA (EMPHASIS) study [23], Birth to Twenty plus (Bt20+) [24], the Healthy Life Trajectories Initiative (HeLTI) [25], the Drakenstein Child Health Study (DCHS) [26], the Foetal Exposure and Epidemiological Transitions: the role of Anaemia in early Life for Non-Communicable Diseases in later life (FOETALforNCD) study [27], the Hormonal and Epigenetic Regulators of Growth (HERO-G) study [28], as well as the Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir (ORCHID) study that is exploring the interactions between metabolic health, HIV and antiretroviral therapy (ClinicalTrials.gov registration no. NCT04991402). However, these studies are focused exclusively on maternal exposures. More recently, the Developmental Origins of Health and Disease (DOHaD) hypothesis was extended to include the Paternal Origins of Health and Disease (POHaD) paradigm, with prenatal exposures to parental smoking being linked to a greater risk of overweight, obesity and type 2 diabetes [29, 30]. Understanding the paternal role on type 2 diabetes risk in offspring will pose a challenge in the SSA context due to the complex social environment and the preponderance of female-headed homes [31].
In addition to the comments made by Christensen and colleagues [1], countries across SSA are at different stages of nutrition transition and economic development, which creates diversity in environmental and lifestyle exposures that have an impact on regional variability in the prevalence of communicable and non-communicable disease risk ([12, 14, 32,33,34]). These exposures may include malnutrition, environmental chemicals, maternal stress and infectious diseases, which may directly and/or indirectly impact on the pathophysiological mechanisms of type 2 diabetes risk in SSA [35,36,37]. Although the mechanisms between these lifestyle factors and type 2 diabetes risk have been recently reviewed [35], the lack of data from SSA is obvious and warrants further investigation.
Abbreviations
- GDM:
-
Gestational diabetes
- SSA:
-
Sub-Saharan Africa
- TB:
-
Tuberculosis
References
Christensen DL, Hjort L, Mpagama SG, Ramayaiya KL (2022) Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations. Diabetologia. https://doi.org/10.1007/s00125-022-05867-3
Goedecke JH, Mendham AE (2022) Pathophysiology of type 2 diabetes in sub-Saharan Africans. Diabetologia 65:1967–1980. https://doi.org/10.1007/s00125-022-05795-2
World Health Organization (2021) Global Tuberculosis Report 2021. World Health Organization, Geneva. Licence: CC BY-NC-SA 3.0 IGO
Menon S, Rossi R, Dusabimana A, Zdraveska N, Bhattacharyya S, Francis J (2020) The epidemiology of tuberculosis-associated hyperglycemia in individuals newly screened for type 2 diabetes mellitus: systematic review and meta-analysis. BMC Infect Dis 20(1):937. https://doi.org/10.1186/s12879-020-05512-7
McEbula V, Crowther NJ, Nagel SE, George JA (2017) Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center. Int J Tuberc Lung Dis 21(2):208–213. https://doi.org/10.5588/ijtld.15.0831
Foe-Essomba JR, Kenmoe S, Tchatchouang S et al (2021) Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders. PLoS One 16(12):e0261246. https://doi.org/10.1371/journal.pone.0261246
Obels I, Ninsiima S, Critchley JA, Huangfu P (2022) Tuberculosis risk among people with diabetes mellitus in Sub-Saharan Africa: a systematic review. Trop Med Int Health. https://doi.org/10.1111/tmi.13733
Jali MV, Mahishale VK, Hiremath MB (2013) Bidirectional screening of tuberculosis patients for diabetes mellitus and diabetes patients for tuberculosis. Diabetes Metab J 37(4):291–295. https://doi.org/10.4093/dmj.2013.37.4.291
World Health Organisation (2021) World Malaria Report 2021. World Health Organization, Geneva. Licence: CC BY-NC-SA 3.0 IGO
Danquah I, Bedu-Addo G, Mockenhaupt FP (2010) Type 2 diabetes mellitus and increased risk for malaria infection. Emerg Infect Dis 16(10):1601–1604. https://doi.org/10.3201/eid1610.100399
Ch'ng JH, Moll K, Wyss K et al (2021) Enhanced virulence of Plasmodium falciparum in blood of diabetic patients. PLoS One 16(6):e0249666. https://doi.org/10.1371/journal.pone.0249666
Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https://doi.org/10.1016/j.diabres.2019.107843
Onubi OJ, Marais D, Aucott L, Okonofua F, Poobalan AS (2016) Maternal obesity in Africa: a systematic review and meta-analysis. J Public Health 38(3):e218–e231. https://doi.org/10.1093/pubmed/fdv138
Muche AA, Olayemi OO, Gete YK (2019) Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis. Arch Public Health 77:36. https://doi.org/10.1186/s13690-019-0362-0
Chivese T, Norris SA, Levitt NS (2019) Progression to type 2 diabetes mellitus and associated risk factors after hyperglycemia first detected in pregnancy: A cross-sectional study in Cape Town, South Africa. PLoS Med 16(9):e1002865. https://doi.org/10.1371/journal.pmed.1002865
Clausen TD, Mathiesen ER, Hansen T et al (2008) High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 31(2):340–346. https://doi.org/10.2337/dc07-1596
Steyn A, Crowther NJ, Norris SA, Rabionet R, Estivill X, Ramsay M (2019) Epigenetic modification of the pentose phosphate pathway and the IGF-axis in women with gestational diabetes mellitus. Epigenomics 11(12):1371–1385. https://doi.org/10.2217/epi-2018-0206
Dias S, Adam S, Abrahams Y, Rheeder P, Pheiffer C (2021) Adiponectin DNA methylation in South African women with gestational diabetes mellitus: Effects of HIV infection. PLoS One 16(3):e0248694. https://doi.org/10.1371/journal.pone.0248694
Dias S, Adam S, Rheeder P, Louw J, Pheiffer C (2019) Altered genome-wide DNA methylation in peripheral blood of south african women with gestational diabetes mellitus. Int J Mol Sci 20(23):5828. https://doi.org/10.3390/ijms20235828
Pheiffer C, Dias S, Rheeder P, Adam S (2018) Decreased expression of circulating miR-20a-5p in south African women with gestational diabetes mellitus. Mol Diagn Ther 22(3):345–352. https://doi.org/10.1007/s40291-018-0325-0
Pheiffer C, Dias S, Rheeder P, Adam S (2019) MicroRNA profiling in HIV-infected south african women with gestational diabetes mellitus. Mol Diagn Ther 23(4):499–505. https://doi.org/10.1007/s40291-019-00404-2
Clouse K, Malope-Kgokong B, Bor J, Nattey C, Mudau M, Maskew M (2020) The South African National HIV Pregnancy Cohort: evaluating continuity of care among women living with HIV. BMC Public Health 20(1):1662. https://doi.org/10.1186/s12889-020-09679-1
Chandak GR, Silver MJ, Saffari A et al (2017) Protocol for the EMPHASIS study; epigenetic mechanisms linking maternal pre-conceptional nutrition and children’s health in India and Sub-Saharan Africa. BMC Nutr 3:81. https://doi.org/10.1186/s40795-017-0200-0
Richter L, Norris S, Pettifor J, Yach D, Cameron N (2007) Cohort profile: Mandela’s children: the 1990 birth to twenty study in South Africa. Int J Epidemiol 36(3):504–511. https://doi.org/10.1093/ije/dym016
Norris SA, Draper CE, Prioreschi A et al (2022) Building knowledge, optimising physical and mental health and setting up healthier life trajectories in South African women (Bukhali): a preconception randomised control trial part of the Healthy Life Trajectories Initiative (HeLTI). BMJ Open 12(4):e059914. https://doi.org/10.1136/bmjopen-2021-059914
Zar HJ, Barnett W, Myer L, Stein DJ, Nicol MP (2015) Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study. Thorax 70(6):592–594. https://doi.org/10.1136/thoraxjnl-2014-206242
Hjort L, Lykke Moller S, Minja D et al (2019) FOETAL for NCD-foetal exposure and epidemiological transitions: the role of anaemia in early life for non-communicable diseases in later life: a prospective preconception study in rural Tanzania. BMJ Open 9(5):e024861. https://doi.org/10.1136/bmjopen-2018-024861
Moore SE, Doel AM, Ong KK et al (2020) Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description. Gates Open Res 4:25. https://doi.org/10.12688/gatesopenres.13101.1
Soubry A (2018) POHaD: why we should study future fathers. Environ Epigenet 4(2):dvy007. https://doi.org/10.1093/eep/dvy007
Rogers JM (2019) Smoking and pregnancy: epigenetics and developmental origins of the metabolic syndrome. Birth Defects Res 111(17):1259–1269. https://doi.org/10.1002/bdr2.1550
Saad GE, Ghattas H, Wendt A et al (2022) Paving the way to understanding female-headed households: variation in household composition across 103 low- and middle-income countries. J Glob Health 12:04038. https://doi.org/10.7189/jogh.12.04038
Dwyer-Lindgren L, Cork MA, Sligar A et al (2019) Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature 570(7760):189–193. https://doi.org/10.1038/s41586-019-1200-9
Law I, Floyd K, African TBPSG (2020) National tuberculosis prevalence surveys in Africa, 2008-2016: an overview of results and lessons learned. Trop Med Int Health 25(11):1308–1327. https://doi.org/10.1111/tmi.13485
Weiss DJ, Lucas TCD, Nguyen M et al (2019) Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study. Lancet 394(10195):322–331. https://doi.org/10.1016/S0140-6736(19)31097-9
Fernandez-Twinn DS, Hjort L, Novakovic B, Ozanne SE, Saffery R (2019) Intrauterine programming of obesity and type 2 diabetes. Diabetologia 62(10):1789–1801. https://doi.org/10.1007/s00125-019-4951-9
Wells JC, Sawaya AL, Wibaek R et al (2020) The double burden of malnutrition: aetiological pathways and consequences for health. Lancet 395(10217):75–88. https://doi.org/10.1016/s0140-6736(19)32472-9
Pheiffer C, Dias S, Adam S (2020) Intimate partner violence: a risk factor for gestational diabetes. Int J Environ Res Public Health 17(21):7843. https://doi.org/10.3390/ijerph17217843
Authors’ relationships and activities
The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Contribution statement
All authors were responsible for drafting the letter and revising it critically for important intellectual content. All authors approved the version to be published.
Funding
JHG and CP are supported by the South African Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Goedecke, J.H., Pheiffer, C. & Mendham, A.E. Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations. Reply to Christensen D, Hjort L, Mpagama S et al [letter]. Diabetologia 66, 780–782 (2023). https://doi.org/10.1007/s00125-022-05859-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-022-05859-3